Tetramethylchloromethylrosamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: Tetramethylchloromethylrosamine
• 英文别名: [9-[4-(chloromethyl)phenyl]-6-(dimethylamino)xanthen-3-ylidene]-dimethylazanium
• 化学式: C24H24ClN2O+
• 分子量: 391.9
• InChiKey: XUDZMIGAJMGETI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  28
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  15.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] CELL-PERMEABLE PROBES FOR IDENTIFICATION AND IMAGING OF SIALIDASES<br/>[FR] SONDES PERMÉABLES AUX CELLULES POUR L'IDENTIFICATION ET L'IMAGERIE DE SIALIDASES
  申请人：ACADEMIA SINICA

  公开号：WO2014031498A1

  公开（公告）日：2014-02-27

  Provided herein are novel irreversible sialidase inhibitors. These compounds can be conjugated with a detectable tagging moiety such as azide-annexed biotin via CuAAC for isolation and identification of sialidases. The provided compounds and the corresponding detectable conjugates are useful for detecting sialidase-containing pathogens and imaging in situ sialidase activities under physiological conditions.

  提供了一种新型的不可逆唾液酸酶抑制剂。这些化合物可以通过点击化学（CuAAC）与可检测的标记基团（如叠氮基连在生物素上）进行偶联，用于分离和识别唾液酸酶。所提供的化合物及相应的可检测偶联物可用于检测含有唾液酸酶的病原体，以及在生理条件下对唾液酸酶活性进行成像。
• [EN] PHOSPHOLIPID-FLAVAGLINE CONJUGATES AND METHODS OF USING THE SAME FOR TARGETED CANCER THERAPY<br/>[FR] CONJUGUÉS PHOSPHOLIPIDE-FLAVAGLINE ET PROCÉDÉS D'UTILISATION DE CEUX-CI POUR UNE THÉRAPIE ANTICANCÉREUSE CIBLÉE
  申请人：CELLECTAR BIOSCIENCES INC

  公开号：WO2021072300A1

  公开（公告）日：2021-04-15

  Disclosed herein are phospholipid ether (PLE) molecules. Further provided are phospholipid-flavagline conjugates. The phospholipid-flavagline conjugate may include a PLE conjugated to a flavagline via a linker. Further provided herein are methods of treating cancer in a subject and methods of targeting a drug to a tumor or cancer cell in a subject.

  本文披露了磷脂醚（PLE）分子。进一步提供了磷脂醚-黄樟素共轭物。磷脂醚-黄樟素共轭物可能包括通过连接剂将PLE与黄樟素共轭的结构。本文还提供了在受试者中治疗癌症的方法以及将药物靶向肿瘤或癌细胞的方法。
• Novel chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy
  申请人：Detty R. Michael

  公开号：US20060040908A1

  公开（公告）日：2006-02-23

  Provided are chalcogenoxanthylium compounds which can effectively be used as sensitizers in photodynamic therapy, virucides in photodynamic antimicrobial chemotherapy and reversal agents of Pgp function in cancer cells. Further provided is a general method for the preparation of chalcogenoxanthylium compounds.

  提供了硫、硒和碲氧杂芴阳离子化合物，可有效用作光动力疗法的增敏剂、光动力抗微生物化疗的病毒灭活剂以及癌细胞Pgp功能的逆转剂。还提供了一种制备硫、硒和碲氧杂芴阳离子化合物的通用方法。
• COMPOSITIONS AND METHODS FOR QUADRICYCLANE MODIFICATION OF BIOMOLECULES
  申请人：Sletten Ellen May

  公开号：US20130244267A1

  公开（公告）日：2013-09-19

  The present disclosure features a strain-promoted [2+2+2] reaction that can be carried out under physiological conditions. In general, the reaction involves reacting a pi-electrophile with a low lying LUMO with a quadricyclane on a biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo and in vitro. The reaction is compatible with modification of living cells. In certain embodiments, the pi-electrophile can comprise a molecule of interest that is desired for delivery to a quadricyclane-containing biomolecule via [2+2+2] reaction.

  本公开揭示了一种在生理条件下可以进行的应变促进的[2+2+2]反应。一般来说，该反应涉及将一个π-亲电体与生物分子上的低能LUMO与四环烷基进行反应，生成一个共价修饰的生物分子。该反应的选择性及其与水性环境的兼容性使其可以在体内和体外应用。该反应与修饰活细胞兼容。在某些实施例中，π-亲电体可以包括所需用于通过[2+2+2]反应传递到含有四环烷基的生物分子的感兴趣分子。
• Compositions and Methods for Modification of Biomolecules
  申请人：JEWETT JOHN C.

  公开号：US20110207147A1

  公开（公告）日：2011-08-25

  Provided are modified cycloalkyne compounds; and methods of use of such compounds in modifying biomolecules. Embodiments include a cycloaddition reaction that can be carried out under physiological conditions. The cycloaddition reaction involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo and in vitro.

  提供了经修改的环炔烃化合物；以及使用这些化合物修改生物分子的方法。实施例包括可以在生理条件下进行的环加成反应。该环加成反应涉及将经修改的环炔烃与靶生物分子上的偶氮基团反应，生成共价修饰的生物分子。该反应的选择性及其与水性环境的兼容性使其适用于体内和体外应用。